Clinical Trial Update: Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia [Phase 3]

View source ↗

Summary

Clinical trial update for bendamustine hydrochloride injection in previously untreated chronic lymphocytic leukemia (Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Bendamustine hydrochloride injection (bendamustine hydrochloride)

Snippet

Sponsor: Shandong Lanjin Pharmaceuticals Co.,Ltd | Conditions: Chronic Lymphocytic Leukemia, Leukemia | Phase 3 | Status: UNKNOWN